Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures

URL

https://www.nature.com/articles/s41587-020-0577-1

Authors

Nikolai Eroshenko, Taylor Gill, Marianna K. Keaveney, George M. Church, Jose M. Trevejo, and Hannu Rajaniemi

Published Date

June 5, 2020

Publication

Nature Biotechnology

Organization

Helix Nanotechnologies

Description

This is a correspondence paper.

Additional Information

Eroshenko, N., Gill, T., Keaveney, M.K. et al. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures. Nat Biotechnol 38, 789–791 (2020). https://doi.org/10.1038/s41587-020-0577-1

Medium

document

Topics

adverse events,antibody dependent enhancement (ADE),COVID-19,vaccine systemic and virological concerns,vaccines